PODOPHYLLIN COMPOUND PAINT BPC 1973

Indications

• Topical antiseptic
• Skin irritations
• Minor cuts and abrasions
• Protective barrier for skin

Dosage

Children: The dosage for paediatric patients should be determined based on the specific product and clinical condition. Refer to the BNF for Children for guidance.

Adults: The dosage for adults varies based on formulation and condition treated. Refer to specific product guidelines.

Mechanism of action

Benzoin acts as a mild antiseptic and astringent. It is thought to exert its effects by forming a protective barrier on the skin and mucous membranes, helping to prevent infection and promote healing. The exact mechanism of action at the molecular level is not fully elucidated; however, it may involve the stabilization of cell membranes and modulation of inflammatory responses.

Pharmacodynamics

Benzoin exhibits local irritant effects when applied topically. It stimulates the sensory nerves in the skin, leading to increased blood flow and promoting the healing process. Its astringent properties help to reduce secretions and tighten tissues, which can be beneficial in conditions involving skin irritation or inflammation.

Pharmacokinetics

The pharmacokinetics of benzoin, when applied topically, are characterized by minimal systemic absorption. It primarily acts at the site of application. Any absorption that occurs is limited, and hence, systemic effects are rare. The duration of action is influenced by the formulation and the condition of the skin at the application site.

Pregnancy

Safety in pregnancy has not been established. Use with caution and only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Use with caution. It is not known whether benzoin is excreted in human milk.

Storage

Store in a well-closed container at room temperature. Protect from light.

Formulations

• {'formulation': 'Benzoin tincture', 'concentration': 'Various concentrations available'}
• {'formulation': 'Benzoin resin', 'concentration': 'Available as powdered resin'}

Indications

• Condylomata acuminata (genital warts)
• Bowenoid papulosis
• Certain types of skin cancers
• Actinic keratosis

Dosage

Children: Refer to the BNF for Children for appropriate dosing information based on specific conditions and formulations.

Adults: Refer to the BNF for appropriate dosing information based on specific conditions and formulations.

Mechanism of action

Podophyllum exerts its therapeutic effects by inhibiting the enzyme topoisomerase II, which is essential for DNA replication and cell division. This inhibition leads to the disruption of the mitotic process in rapidly dividing cells, ultimately resulting in cell death. The compound's action is particularly effective against neoplastic cells and viral-infected cells, contributing to its use in oncology and dermatology.

Pharmacodynamics

The pharmacodynamics of podophyllum are characterized by its antimitotic and cytotoxic effects. By interfering with the normal cell cycle, particularly during the S and G2 phases, podophyllum induces apoptosis in affected cells. The extent of its effect is dose-dependent, with higher concentrations leading to increased cell death. Additionally, podophyllum has shown activity against certain viruses, including human papillomavirus (HPV), which is responsible for genital warts and other lesions.

Pharmacokinetics

Podophyllum is usually administered topically, which limits systemic absorption. When applied to the skin, the bioavailability is low, and systemic effects are minimal. However, when ingested or improperly used, it can lead to significant toxicity. The compound is metabolized in the liver, and its metabolites are excreted primarily via the kidneys. The half-life of podophyllum can vary based on the route of administration and the individual's metabolic rate.

Contra-indications

• Pregnancy
• Lactation
• Severe liver dysfunction
• Hypersensitivity to podophyllum or any of its components

Adverse effects

• Nausea
• Vomiting
• Abdominal pain
• Diarrhea
• Headache
• Dizziness
• Skin irritation
• Local necrosis at the application site

Interactions

• May interact with other cytotoxic agents
• Caution advised when used with anticoagulants due to potential for increased bleeding

Precautions

• Use with caution in patients with liver impairment
• Monitor for signs of toxicity, especially in patients receiving other medications that affect liver function
• Not to be used in large areas of skin or on open wounds

Pregnancy

Podophyllum is contraindicated during pregnancy due to its potential teratogenic effects.

Breast-feeding

The use of podophyllum during breastfeeding is not recommended due to the risk of serious adverse effects in the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Topical solution
• Gel
• Ointment